These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 15044324)
1. Urokinase-type plasminogen activator receptor is involved in mediating the apoptotic effect of cleaved high molecular weight kininogen in human endothelial cells. Cao DJ; Guo YL; Colman RW Circ Res; 2004 May; 94(9):1227-34. PubMed ID: 15044324 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in vascular cells by plasminogen activator inhibitor-1 and high molecular weight kininogen correlates with their anti-adhesive properties. Al-Fakhri N; Chavakis T; Schmidt-Wöll T; Huang B; Cherian SM; Bobryshev YV; Lord RS; Katz N; Preissner KT Biol Chem; 2003 Mar; 384(3):423-35. PubMed ID: 12715893 [TBL] [Abstract][Full Text] [Related]
3. Kininostatin associates with membrane rafts and inhibits alpha(v)beta3 integrin activation in human umbilical vein endothelial cells. Wu Y; Rizzo V; Liu Y; Sainz IM; Schmuckler NG; Colman RW Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1968-75. PubMed ID: 17585065 [TBL] [Abstract][Full Text] [Related]
4. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. Colman RW; Pixley RA; Najamunnisa S; Yan W; Wang J; Mazar A; McCrae KR J Clin Invest; 1997 Sep; 100(6):1481-7. PubMed ID: 9294114 [TBL] [Abstract][Full Text] [Related]
5. Apoptotic effect of cleaved high molecular weight kininogen is regulated by extracellular matrix proteins. Guo YL; Wang S; Cao DJ; Colman RW J Cell Biochem; 2003 Jun; 89(3):622-32. PubMed ID: 12761895 [TBL] [Abstract][Full Text] [Related]
6. Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Wickström SA; Alitalo K; Keski-Oja J Cancer Res; 2002 Oct; 62(19):5580-9. PubMed ID: 12359771 [TBL] [Abstract][Full Text] [Related]
7. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation. Chavakis T; Kanse SM; May AE; Preissner KT Biochem Soc Trans; 2002 Apr; 30(2):168-73. PubMed ID: 12023845 [TBL] [Abstract][Full Text] [Related]
8. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions. Chavakis T; Kanse SM; Lupu F; Hammes HP; Müller-Esterl W; Pixley RA; Colman RW; Preissner KT Blood; 2000 Jul; 96(2):514-22. PubMed ID: 10887113 [TBL] [Abstract][Full Text] [Related]
9. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain. O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916 [TBL] [Abstract][Full Text] [Related]
10. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells. Salasznyk RM; Zappala M; Zheng M; Yu L; Wilkins-Port C; McKeown-Longo PJ Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53. Besch R; Berking C; Kammerbauer C; Degitz K Cell Death Differ; 2007 Apr; 14(4):818-29. PubMed ID: 17110957 [TBL] [Abstract][Full Text] [Related]
13. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945 [TBL] [Abstract][Full Text] [Related]
14. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen. Chavakis T; Kanse SM; Pixley RA; May AE; Isordia-Salas I; Colman RW; Preissner KT FASEB J; 2001 Nov; 15(13):2365-76. PubMed ID: 11689462 [TBL] [Abstract][Full Text] [Related]
16. Fibronectin promotes brain capillary endothelial cell survival and proliferation through alpha5beta1 and alphavbeta3 integrins via MAP kinase signalling. Wang J; Milner R J Neurochem; 2006 Jan; 96(1):148-59. PubMed ID: 16269008 [TBL] [Abstract][Full Text] [Related]
17. Cleaved high-molecular-weight kininogen and its domain 5 inhibit migration and invasion of human prostate cancer cells through the epidermal growth factor receptor pathway. Liu Y; Pixley R; Fusaro M; Godoy G; Kim E; Bromberg ME; Colman RW Oncogene; 2009 Jul; 28(30):2756-65. PubMed ID: 19483730 [TBL] [Abstract][Full Text] [Related]
18. The inhibitory effect of HKa in endothelial cell tube formation is mediated by disrupting the uPA-uPAR complex and inhibiting its signaling and internalization. Liu Y; Cao DJ; Sainz IM; Guo YL; Colman RW Am J Physiol Cell Physiol; 2008 Jul; 295(1):C257-67. PubMed ID: 18495808 [TBL] [Abstract][Full Text] [Related]
19. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors. Basire A; Sabatier F; Ravet S; Lamy E; Mialhe A; Zabouo G; Paul P; Gurewich V; Sampol J; Dignat-George F Thromb Haemost; 2006 Apr; 95(4):678-88. PubMed ID: 16601839 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms by which cleaved kininogen inhibits endothelial cell differentiation and signalling. Colman RW; Wu Y; Liu Y Thromb Haemost; 2010 Nov; 104(5):875-85. PubMed ID: 20886177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]